ATRX modulates the escape from a telomere crisis

Area of Science:

• Oncology
• Genetics
• Cell Biology

Background:

• Telomere maintenance is crucial for cancer progression.
• While telomerase is common, 15% of cancers use the alternative lengthening of telomeres (ALT) pathway.
• Loss-of-function mutations in the Alpha Thalassemia/Mental Retardation Syndrome X-Linked (ATRX) gene are prevalent in ALT cancers.

Purpose of the Study:

• To investigate if ATRX loss and telomere dysfunction can initiate the ALT pathway.
• To determine if this initiation confers replicative immortality.
• To explore the effects in both fibroblasts and epithelial cancer cells.

Main Methods:

• Inducing telomere dysfunction and ATRX loss in human fibroblasts.
• Applying similar conditions to HCT116 epithelial cancer cells.
• Analyzing telomere length, C-circle formation, and telomere repeat sequences.

Main Results:

• Loss of ATRX and telomere crisis were sufficient to activate the ALT pathway and confer immortality in fibroblasts.
• In epithelial cells, ATRX loss induced a transient ALT-like pathway with rapid telomere elongation and C-circles.
• This ALT activation was transient, leading to cell death or telomerase activation, with cell-line specific variant repeat enrichment observed.

Conclusions:

• Loss of ATRX coupled with telomere dysfunction during crisis is a key driver for initiating the ALT pathway.
• This mechanism confers replicative immortality in fibroblasts and transient ALT activation in epithelial cells.
• Variant telomere repeat enrichment suggests a cell-specific adaptation during ALT activation.